These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6214877)

  • 21. Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity.
    Pawelec GP; Hadam MR; Ziegler A; Lohmeyer J; Rehbein A; Kumbier I; Wernet P
    J Immunol; 1982 Apr; 128(4):1892-6. PubMed ID: 6460813
    [No Abstract]   [Full Text] [Related]  

  • 22. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
    Hummel S; Wilms D; Vitacolonna M; Zöller M
    J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
    Hamilton BL; Bevan MJ; Parkman R
    J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
    Lamb LS; Gee AP; Henslee-Downey PJ; Geier SS; Hazlett L; Pati AR; Godder K; Abhyankar SA; Turner MW; Lee C; Harris WG; Parrish RS
    Bone Marrow Transplant; 1998 Mar; 21(5):461-71. PubMed ID: 9535038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human-mouse mixed lymphocyte cultures.
    Boylston AW; Anderson RL
    Immunology; 1978 Sep; 35(3):455-61. PubMed ID: 151664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities.
    Kumagai K; Itoh K; Suzuki R; Hinuma S; Saitoh F
    J Immunol; 1982 Jul; 129(1):388-94. PubMed ID: 6979572
    [No Abstract]   [Full Text] [Related]  

  • 29. Transplantation.
    Transplant Proc; 1983 Jun; 15(2):1643-65. PubMed ID: 6224324
    [No Abstract]   [Full Text] [Related]  

  • 30. Receptors for immunoglobulins and activation markers on human T lymphocytes.
    Moretta A; Mingari MC; Corte G; Moretta L
    Clin Haematol; 1982 Oct; 11(3):697-709. PubMed ID: 6217008
    [No Abstract]   [Full Text] [Related]  

  • 31. Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.
    Auletta JJ; Devecchio JL; Ferrara JL; Heinzel FP
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):834-47. PubMed ID: 15570252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.
    Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K
    Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process.
    Takeda K; Moore MW; Dennert G
    J Immunol; 1994 May; 152(9):4407-16. PubMed ID: 8157961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft-versus-host and cytotoxic activity of rat thoracic duct lymphocytes fractionated by zonal centrifugation after culture on allogeneic fibroblasts.
    Bowers WE
    J Immunol; 1974 Oct; 113(4):1252-61. PubMed ID: 4153365
    [No Abstract]   [Full Text] [Related]  

  • 36. "Clonal selection and after," and after.
    Gershon RK
    N Engl J Med; 1979 May; 300(19):1105-7. PubMed ID: 34794
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular modulation of acute graft-vs.-host disease.
    Colby C; Sykes M; Sachs DH; Spitzer TR
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):287-93. PubMed ID: 9502295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target-effector interactions in the rat natural killer cell system. I. The measurement of cytotoxicity at the single cell level.
    Flexman JP; Shellam GR
    Eur J Immunol; 1982 Jun; 12(6):457-63. PubMed ID: 7117361
    [No Abstract]   [Full Text] [Related]  

  • 39. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine A: a tool for analyzing the function of class I MHC antigen-reactive T cells in vivo.
    Hodgkin PD; Dixon JE; Andrus L; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):968-9. PubMed ID: 6611620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.